{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:36:53Z","timestamp":1789940213198,"version":"4.0.1"},"reference-count":145,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1053\/beha.2001.0153","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:54:50Z","timestamp":1032429290000},"page":"531-551","source":"Crossref","is-referenced-by-count":39,"title":["Myeloproliferative disorders"],"prefix":"10.1053","volume":"14","author":[{"given":"Anthony J.","family":"Bench","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.P.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.P.","family":"Huntly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth P.","family":"Nacheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2001.0153_RF1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","article-title":"Some speculations on the myeloproliferative syndromes","volume":"6","author":"Dameshek","year":"1951","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0950-3536(98)80035-8","article-title":"Diagnosis and classification of erythrocytosis and thrombocytosis","volume":"11","author":"Pearson","year":"1998","journal-title":"Bailliere\u2019s Clinical Haematology"},{"key":"10.1053\/beha.2001.0153_RF3","first-page":"361","article-title":"Evaluation of clonality in myeloid stem-cell disorders","volume":"36","author":"Gale","year":"1999","journal-title":"Seminars in Hematology"},{"key":"10.1053\/beha.2001.0153_RF4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM197610212951702","article-title":"Polycythemia vera: stem cell and probable clonal origin of the disease","volume":"295","author":"Adamson","year":"1976","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0153_RF5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/blood.V51.2.189.189","article-title":"Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis","volume":"51","author":"Jacobson","year":"1978","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V58.5.916.916","article-title":"Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell","volume":"58","author":"Fialkow","year":"1981","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V88.1.59.59","article-title":"Nonrandom X-inactivation patterns in normal females: Lyonization ratios vary with age","volume":"88","author":"Busque","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF8","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood.V83.10.2899.2899","article-title":"Tissue specificity of X-chromosome inactivation patterns","volume":"83","author":"Gale","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF9","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1182\/blood.V88.7.2690.bloodjournal8872690","article-title":"Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera","volume":"88","author":"Asimakopoulos","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V89.1.128","article-title":"Clonality analysis of hematopoiesis in essential thrombocythaemia: advantages of studying T lymphocytes and platelets","volume":"89","author":"El-Kassar","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood.V93.2.417","article-title":"A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications","volume":"93","author":"Harrison","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.1365-2141.1997.1933010.x","article-title":"Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes","volume":"97","author":"Champion","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0153_RF13","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2141.1997.2573078.x","article-title":"Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age","volume":"98","author":"Gale","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0153_RF14","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1073\/pnas.95.7.3862","article-title":"An X chromosome gene regulates hematopoietic stem cell kinetics","volume":"95","author":"Abkowitz","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0153_RF15","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1182\/blood.V95.7.2449","article-title":"X-linked genetic factors regulate hematopoietic stem-cell kinetics in females","volume":"95","author":"Christensen","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0950-3536(98)80040-1","article-title":"Hematopoietic progenitors and signal transduction in polycythemia vera and primary thrombocythemia","volume":"11","author":"Kralovics","year":"1998","journal-title":"Bailliere\u2019s Clinical Haematology"},{"key":"10.1053\/beha.2001.0153_RF17","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJM197406132902419","article-title":"Bone marrow responses in polycythemia vera","volume":"290","author":"Prchal","year":"1974","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0153_RF18","first-page":"64","article-title":"In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders","volume":"34","author":"Weinberg","year":"1997","journal-title":"Seminars in Hematology"},{"key":"10.1053\/beha.2001.0153_RF19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2141.1993.tb08271.x","article-title":"Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications","volume":"83","author":"Juvonen","year":"1993","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0153_RF20","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1073\/pnas.90.10.4495","article-title":"Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis","volume":"90","author":"de la Chapelle","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0153_RF21","first-page":"70","article-title":"Erythropoietin receptor mutations and human disease","volume":"34","author":"Gregg","year":"1997","journal-title":"Seminars in Haematology"},{"key":"10.1053\/beha.2001.0153_RF22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood.V80.4.891.891","article-title":"Polycythemia vera II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor","volume":"80","author":"Dai","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.1994.tb03246.x","article-title":"Polycythaemia vera III. Burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression","volume":"86","author":"Dai","year":"1994","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0153_RF24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.V83.1.99.99","article-title":"Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium","volume":"83","author":"Correa","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1182\/blood.V93.1.125","article-title":"Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to ac-mpl mutation or to an autocrine stimulation by Mpl-L","volume":"93","author":"Taksin","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF26","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood.V96.10.3310","article-title":"Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia","volume":"96","author":"Axelrad","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.1993.tb04624.x","article-title":"Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor beta 1, produced in normal amount, in patients with essential thrombocythaemia","volume":"83","author":"Zauli","year":"1993","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0153_RF28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.onc.1200942","article-title":"The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera","volume":"14","author":"Asimakopoulos","year":"1997","journal-title":"Oncogene"},{"key":"10.1053\/beha.2001.0153_RF29","first-page":"492","article-title":"An increase in mpl splice variants in polycythemia vera platelets","volume":"94","author":"Moliterno","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ng0198-49","article-title":"An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia","volume":"18","author":"Wiestner","year":"1998","journal-title":"Nature Genetics"},{"key":"10.1053\/beha.2001.0153_RF31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM199802263380903","article-title":"Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera","volume":"338","author":"Moliterno","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0153_RF32","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/blood.V90.10.4031","article-title":"Markedly reduced expression of platelet c-mpl receptor in essential thrombocythaemia","volume":"90","author":"Horikawa","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF33","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V94.8.2555.420k14_2555_2561","article-title":"Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera","volume":"94","author":"Moliterno","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/blood.V96.2.771","article-title":"Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis","volume":"96","author":"Tefferi","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF35","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM199802263380902","article-title":"Expression of Bcl-x in erythroid precursors from patients with polycythemia vera","volume":"338","author":"Silva","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0153_RF36","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood.V95.8.2569","article-title":"Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera","volume":"95","author":"Temerinac","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1096-9896(200001)190:1<61::AID-PATH502>3.0.CO;2-#","article-title":"Expression of the imprinted tumour-suppressor gene H19 is tightly regulated during normal haematopoiesis and is reduced in haematopoietic precursors of patients with the myeloproliferative disease polycythaemia vera","volume":"190","author":"Nunez","year":"2000","journal-title":"Journal of Pathology"},{"key":"10.1053\/beha.2001.0153_RF38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V72.2.386.386","article-title":"A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course","volume":"72","author":"Swolin","year":"1988","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0025-6196(12)61011-8","article-title":"Chromosome studies in 104 patients with polycythemia vera","volume":"66","author":"Diez-Martin","year":"1991","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1053\/beha.2001.0153_RF40","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0950-3536(98)80041-3","article-title":"Molecular genetics and cytogenetics of myeloproliferative disorders","volume":"11","author":"Bench","year":"1998","journal-title":"Bailliere\u2019s Clinical Haematology"},{"key":"10.1053\/beha.2001.0153_RF41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0165-4608(87)90183-X","article-title":"A chromosomal profile of polycythemia vera","volume":"25","author":"Rege-Cambrin","year":"1987","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF42","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V88.3.1013.1013","article-title":"Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system","volume":"88","author":"Dupriez","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1365-2141.1997.1722990.x","article-title":"Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases","volume":"98","author":"Reilly","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0153_RF44","first-page":"497","article-title":"Interphase FISH (I-FISH) in polycythemia vera (PV): a new tool for diagnosis and for providing insights into the biology of abnormal clones","volume":"94","author":"Montella","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1365-2141.2000.02242.x","article-title":"The incidences of trisomy 8, trisomy 9 and D20S108 deletion in polycythaemia vera: an analysis of blood granulocytes using interphase fluorescence in situ hybridization","volume":"110","author":"Westwood","year":"2000","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0153_RF46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0165-4608(93)90075-W","article-title":"Frequency and photographs of HGM11 chromosome anomalies in bone marrow samples from 3,996 patients with malignant hematologic neoplasms","volume":"68","author":"Dewald","year":"1993","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF47","first-page":"127","article-title":"Cytogenetics of myelodysplastic syndromes","volume":"33","author":"Fenaux","year":"1996","journal-title":"Seminars in Hematology"},{"key":"10.1053\/beha.2001.0153_RF48","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/1097-0142(19920915)70:4+<1701::AID-CNCR2820701609>3.0.CO;2-S","article-title":"Cytogenetic analysis in the diagnosis of acute leukemia","volume":"70","author":"Heim","year":"1992","journal-title":"Cancer"},{"key":"10.1053\/beha.2001.0153_RF49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ng0497supp-417","article-title":"A breakpoint map of recurrent chromosomal rearrangements in human neoplasia","volume":"15","author":"Mitelman","year":"1997","journal-title":"Nature Genetics"},{"key":"10.1053\/beha.2001.0153_RF50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-4608(84)90009-8","article-title":"Haematologic manifestations associated with deletions of the long arm of chromosome 20","volume":"12","author":"Davis","year":"1984","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF51","first-page":"67","article-title":"The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders","volume":"8","author":"Campbell","year":"1994","journal-title":"Leukemia"},{"key":"10.1053\/beha.2001.0153_RF52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0165-4608(92)90043-8","article-title":"Clinical significance of the del 20(q) chromosome in haematologic disorders","volume":"62","author":"Aatola","year":"1992","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF53","first-page":"1315","article-title":"Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system\u2014a report on 408 cases","volume":"7","author":"Morel","year":"1993","journal-title":"Leukemia"},{"key":"10.1053\/beha.2001.0153_RF54","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF55","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0145-2126(93)90038-M","article-title":"De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features?","volume":"17","author":"Wattel","year":"1993","journal-title":"Leukemia Research"},{"key":"10.1053\/beha.2001.0153_RF56","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2141.2000.01868.x","article-title":"Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes","volume":"108","author":"Sole","year":"2000","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0153_RF57","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood.V83.10.2809.2809","article-title":"Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells","volume":"83","author":"White","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF58","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood.V83.1.305.305","article-title":"A 20q deletion originating in a pluripotent stem cell","volume":"83","author":"Hollings","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF59","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1182\/blood.V87.4.1561.bloodjournal8741561","article-title":"Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes","volume":"87","author":"Asimakopoulos","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF60","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ajcp\/106.5.680","article-title":"Hematologic disorders associated with deletions of chromosome 20q","volume":"106","author":"Kurtin","year":"1996","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1053\/beha.2001.0153_RF61","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1073\/pnas.82.19.6692","article-title":"c-src is consistently conserved in the chromosomal deletion (20q) observed in myeloid disorders","volume":"82","author":"Le Beau","year":"1985","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0153_RF62","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood.V74.5.1768.1768","article-title":"Localization of the SRC oncogene to chromosome band 20q11\u00b72 and loss of this gene with deletion (20q) in two leukemic patients","volume":"74","author":"Morris","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF63","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0165-4608(94)00150-A","article-title":"Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromes","volume":"80","author":"Nacheva","year":"1995","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF64","first-page":"3424","article-title":"Molecular genetics of myeloid leukemia: Identification of the commonly deleted segment of chromosome 20","volume":"82","author":"Roulston","year":"1993","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF65","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1182\/blood.V84.9.3086.3086","article-title":"Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodyslastic syndromes","volume":"84","author":"Asimakopoulos","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/gcc.2870110105","article-title":"Molecular heterogeneity at the breakpoints of smaller 20q deletions","volume":"11","author":"Hollings","year":"1994","journal-title":"Genes, Chromosomes and Cancer"},{"key":"10.1053\/beha.2001.0153_RF67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1098-2264(199802)21:2<75::AID-GCC1>3.0.CO;2-4","article-title":"Refinement of the common deleted segment in myeloid leukemias with a del(20q)","volume":"21","author":"Wang","year":"1998","journal-title":"Genes, Chromosomes and Cancer"},{"key":"10.1053\/beha.2001.0153_RF68","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1038\/sj.onc.1203728","article-title":"Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC\/BAC contig and identification of candidate genes","volume":"19","author":"Bench","year":"2000","journal-title":"Oncogene"},{"key":"10.1053\/beha.2001.0153_RF69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/geno.2000.6215","article-title":"Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map","volume":"67","author":"Wang","year":"2000","journal-title":"Genomics"},{"key":"10.1053\/beha.2001.0153_RF70","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1073\/pnas.93.9.3937","article-title":"A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene, MODY1, and a myeloid leukaemia related gene","volume":"93","author":"Stoffel","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0153_RF71","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/geno.1998.5231","article-title":"A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region","volume":"49","author":"Bench","year":"1998","journal-title":"Genomics"},{"key":"10.1053\/beha.2001.0153_RF72","doi-asserted-by":"crossref","first-page":"9168","DOI":"10.1073\/pnas.150079597","article-title":"The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome\/acute myeloid leukemia with a deletion 5q","volume":"97","author":"Borkhardt","year":"2000","journal-title":"Proceedings of the National Academy of Sciencies of the USA"},{"key":"10.1053\/beha.2001.0153_RF73","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1073\/pnas.94.13.6948","article-title":"Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1\u00b75Mb and preparation of a PAC-based physical map","volume":"94","author":"Zhao","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0153_RF74","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2141.1996.d01-1896.x","article-title":"Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders","volume":"95","author":"Asimakopoulos","year":"1996","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0153_RF75","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/(SICI)1098-2264(200003)27:3<278::AID-GCC8>3.0.CO;2-H","article-title":"Non-random involvement of chromosome 13 in patients with persistent or relapsed disease after bone-marrow transplantation for chronic myeloid leukemia","volume":"27","author":"Chase","year":"2000","journal-title":"Genes, Chromosomes and Cancer"},{"key":"10.1053\/beha.2001.0153_RF76","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0268-960X(05)80013-X","article-title":"Cytogenetic and molecular abnormalities in chronic lymphocytic leukemia","volume":"8","author":"Oscier","year":"1994","journal-title":"Blood Reviews"},{"key":"10.1053\/beha.2001.0153_RF77","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1182\/blood.V86.5.1911.bloodjournal8651911","article-title":"13q deletions in lymphoid malignancies","volume":"86","author":"Liu","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF78","first-page":"589","article-title":"13q14 deletion in non-Hodgkin\u2019s lymphoma: correlation with clinicopathologic features","volume":"84","author":"Cuneo","year":"1999","journal-title":"Haematologica"},{"key":"10.1053\/beha.2001.0153_RF79","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1359::AID-CNCR12>3.0.CO;2-Q","article-title":"Deletions in the 13q14 locus in adult lymphoblastic leukemia: rate of incidence and relevance","volume":"88","author":"Chung","year":"2000","journal-title":"Cancer"},{"key":"10.1053\/beha.2001.0153_RF80","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V96.4.1505","article-title":"High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH","volume":"96","author":"Shaughnessy","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF81","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V95.6.1925","article-title":"Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization","volume":"95","author":"Zojer","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF82","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/gcc.2870140204","article-title":"Genetic analysis of chromosome 13 deletions in BCR\/ABL negative chronic myeloproliferative disorders","volume":"14","author":"Pastore","year":"1995","journal-title":"Genes, Chromosomes and Cancer"},{"key":"10.1053\/beha.2001.0153_RF83","first-page":"4062","article-title":"An analysis of chromosome 13q14 deletions in myelofibrosis using FISH and Southern-based hybridisation","volume":"90","author":"Gardiner","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF84","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood.V91.1.231","article-title":"Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies","volume":"91","author":"La Starza","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF85","first-page":"1437","article-title":"Jr. Hereditary cancer, oncogenes, and antioncogenes","volume":"45","author":"Knudson","year":"1985","journal-title":"Cancer Research"},{"key":"10.1053\/beha.2001.0153_RF86","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1038\/sj.onc.1203653","article-title":"Accommodating haploinsufficient tumor suppressor genes in Knudson\u2019s model","volume":"19","author":"Cook","year":"2000","journal-title":"Oncogene"},{"key":"10.1053\/beha.2001.0153_RF87","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/ng0594-5","article-title":"Human haploinsufficiency-one for sorrow, two for joy","volume":"7","author":"Fisher","year":"1994","journal-title":"Nature Genetics"},{"key":"10.1053\/beha.2001.0153_RF88","first-page":"1206","article-title":"Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias","volume":"55","author":"Pietenpol","year":"1995","journal-title":"Cancer Research"},{"key":"10.1053\/beha.2001.0153_RF89","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1073\/pnas.88.11.5006","article-title":"Genetic basis for p53 overexpression in human breast cancer","volume":"88","author":"Davidoff","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0153_RF90","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/bjc.1998.172","article-title":"Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours","volume":"77","author":"Sedlacek","year":"1998","journal-title":"British Journal of Cancer"},{"key":"10.1053\/beha.2001.0153_RF91","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0092-8674(00)80540-1","article-title":"Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers","volume":"90","author":"Kaghad","year":"1997","journal-title":"Cell"},{"key":"10.1053\/beha.2001.0153_RF92","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/24179","article-title":"The murine gene p27Kipl is haplo-insufficient for tumour suppression","volume":"396","author":"Fero","year":"1998","journal-title":"Nature"},{"key":"10.1053\/beha.2001.0153_RF93","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1093\/emboj\/17.16.4657","article-title":"Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation","volume":"17","author":"Venkatachalam","year":"1998","journal-title":"EMBO Journal"},{"key":"10.1053\/beha.2001.0153_RF94","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1093\/emboj\/18.10.2692","article-title":"Haploid loss of bax leads to accelerated mammary tumor development in C3(1)\/SV40-Tag transgenic mice: reduction in protective apoptotic response at the preneoplastic stage","volume":"18","author":"Shibata","year":"1999","journal-title":"EMBO Journal"},{"key":"10.1053\/beha.2001.0153_RF95","series-title":"Cancer Cytogenetics","author":"Heim","year":"1995"},{"key":"10.1053\/beha.2001.0153_RF96","first-page":"3307","article-title":"Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens","volume":"79","author":"Jenkins","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF97","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-4608(96)00208-7","article-title":"Detection of trisomy 8 using conventional cytogenetic techniques and interphase FISH analysis in 34 myeloid disorders: a comparative study","volume":"94","author":"Arranz","year":"1997","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF98","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood.V82.3.904.904","article-title":"Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: A comparison of banding and fluorescence in situ hybridization","volume":"82","author":"Kibbelaar","year":"1993","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF99","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood.V80.4.1033.1033","article-title":"Simultaneous genotypic and immunophenotypic analysis of interphase cells using dual-colour fluorescence: a demonstration of lineage involvement in polycythemia vera","volume":"80","author":"Price","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF100","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood.V79.7.1823.1823","article-title":"Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes","volume":"79","author":"Kibbelaar","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF101","first-page":"662","article-title":"Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology","volume":"10","author":"Bernell","year":"1996","journal-title":"Leukemia"},{"key":"10.1053\/beha.2001.0153_RF102","first-page":"1654","article-title":"Fluorescence in situ hybridization (FISH) detection of trisomy 8 in myeloid cells in chronic myeloid leukemia (CML): A study of archival blood and bone marrow smears","volume":"8","author":"Nguyen","year":"1994","journal-title":"Leukemia"},{"key":"10.1053\/beha.2001.0153_RF103","first-page":"1139","article-title":"Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia","volume":"86","author":"Mehrotra","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF104","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-4608(94)00286-K","article-title":"Comparative genomic hybridization in acute myeloid leukaemia: a comparison with G-banding and chromosome painting","volume":"82","author":"Nacheva","year":"1995","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-4608(98)00213-1","article-title":"Comparative analysis of G-banding, chromosome painting, locus-specific fluorescence in situ hybridization, and comparative genomic hybridization in chronic myeloid leukemia blast crisis","volume":"111","author":"Gribble","year":"1999","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF106","first-page":"131","article-title":"Detection of numerical chromosomal abnormalities in neoplastic hematopoietic cells by in situ hybridization with a chromosome-specific probe","volume":"136","author":"Anastasi","year":"1990","journal-title":"American Journal of Pathology"},{"key":"10.1053\/beha.2001.0153_RF107","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1098-2264(199808)22:4<321::AID-GCC8>3.0.CO;2-X","article-title":"Gain of 9p in the pathogenesis of polycythemia vera","volume":"22","author":"Chen","year":"1998","journal-title":"Genes, Chromosomes and Cancer"},{"key":"10.1053\/beha.2001.0153_RF108","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-4608(89)90153-2","article-title":"der(1)t(1;9): A specific chromosome abnormality in polycythaemia vera?","volume":"40","author":"den Nijs van Weert","year":"1989","journal-title":"Cytogenetics and Cell Genetics"},{"key":"10.1053\/beha.2001.0153_RF109","first-page":"1059","article-title":"Extra translocation +der(1q9p) is a prognostic indicator in myeloproliferative disorders","volume":"5","author":"Rege-Cambrin","year":"1991","journal-title":"Leukemia"},{"key":"10.1053\/beha.2001.0153_RF110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-4608(97)00206-9","article-title":"Partial trisomy 9 in a patient with polycythemia vera","volume":"97","author":"Blij-Philipsen","year":"1997","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF111","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ajh.2830220206","article-title":"Trisomy 1q in polycythemia vera and its relation to disease transition","volume":"22","author":"Swolin","year":"1986","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0153_RF112","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-4608(91)90177-V","article-title":"A nonrandom primary chromosomal abnormality in myelodysplastic syndromes?","volume":"56","author":"Fonatsch","year":"1991","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF113","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0165-4608(81)90021-2","article-title":"Trisomy 1q and hematologic disorders","volume":"4","author":"Anglani","year":"1981","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF114","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-4608(83)90008-0","article-title":"Chromosome 1q+ in erythroid and granulocyte-monocyte precursors in a patient with essential thrombocythemia","volume":"9","author":"Knuutila","year":"1983","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF115","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood.V90.7.2768","article-title":"BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocytopenia patients: clinical presentation","volume":"90","author":"Blickstein","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF116","first-page":"1754","article-title":"BCR-ABL transcripts in blood and bone marrow aspirates of patients with Philadelphia-negative essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis","volume":"92","author":"Blickstein","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF117","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood.V93.7.2420","article-title":"Patients with essential thrombocythemia do not express BCR-ABL transcripts","volume":"93","author":"Hackwell","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF118","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood.V92.9.3362","article-title":"The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease","volume":"92","author":"Bose","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF119","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0145-2126(84)90013-4","article-title":"Simultaneous occurrence of a T-cell lymphoma and a chronic myelogenous leukemia with an unusual karyotype","volume":"8","author":"Vannier","year":"1984","journal-title":"Leukemia Research"},{"key":"10.1053\/beha.2001.0153_RF120","first-page":"1627","article-title":"A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review","volume":"9","author":"Macdonald","year":"1995","journal-title":"Leukemia"},{"key":"10.1053\/beha.2001.0153_RF121","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ng0198-84","article-title":"FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia\/lymphoma syndrome","volume":"18","author":"Xiao","year":"1998","journal-title":"Nature Genetics"},{"key":"10.1053\/beha.2001.0153_RF122","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.V95.5.1788.005k15_1788_1796","article-title":"FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33)","volume":"95","author":"Guasch","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF123","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V93.4.1381","article-title":"The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1","volume":"93","author":"Popovici","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF124","first-page":"2199","article-title":"Identification of four new variant translocations involving FGFR1 in myeloproliferative disorders with a propensity to evolve to AML","volume":"96","author":"Sohal","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF125","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood.V85.7.1881.bloodjournal8571881","article-title":"A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia\/malignancy associated with t(8;13)(p11;q11): Description of a distinctive clinicopathologic entity","volume":"85","author":"Inhorn","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF126","first-page":"2","article-title":"Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome","volume":"95","author":"Bain","year":"1996","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0153_RF127","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0165-4608(93)90051-M","article-title":"t(5;12)(q31;p12). A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia","volume":"65","author":"Wessels","year":"1993","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF128","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","article-title":"Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation","volume":"77","author":"Golub","year":"1994","journal-title":"Cell"},{"key":"10.1053\/beha.2001.0153_RF129","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1182\/blood.V91.4.1399","article-title":"Fluorescence in situ hybridization chracterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies","volume":"91","author":"Wlodarska","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF130","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1182\/blood.V91.12.4419","article-title":"Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11\u00b72)","volume":"91","author":"Ross","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF131","first-page":"3592","article-title":"Fusion of H4\/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21)","volume":"60","author":"Kulkarni","year":"2000","journal-title":"Cancer Research"},{"key":"10.1053\/beha.2001.0153_RF132","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood.V96.2.699","article-title":"ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain","volume":"96","author":"Xiao","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF133","doi-asserted-by":"crossref","first-page":"14845","DOI":"10.1073\/pnas.93.25.14845","article-title":"The TEL\/platelet-derived growth factor \u03b2 receptor (PDGR\u03b2R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGR\u03b2R kinase-dependent signaling pathways","volume":"93","author":"Carroll","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0153_RF134","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1182\/blood.V92.5.1735","article-title":"Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome","volume":"92","author":"Reiter","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF135","first-page":"34","article-title":"The novel activation of ABL by fusion to an ets-related gene, TEL","volume":"55","author":"Papadopoulous","year":"1995","journal-title":"Cancer Research"},{"key":"10.1053\/beha.2001.0153_RF136","first-page":"4220","article-title":"Breakpoint heterogeneity in t(10;11) translocation in AML-M4\/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis","volume":"55","author":"Beverloo","year":"1995","journal-title":"Cancer Research"},{"key":"10.1053\/beha.2001.0153_RF137","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/(SICI)1098-2264(199801)21:1<70::AID-GCC9>3.0.CO;2-5","article-title":"Characterization of a t(8;13)(p11;q11-12) in an atypical myeloproliferative disorder","volume":"21","author":"Smedley","year":"1998","journal-title":"Genes, Chromosomes and Cancer"},{"key":"10.1053\/beha.2001.0153_RF138","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2141.1987.tb01331.x","article-title":"A myeloproliferative disease in two infants associated with eosinophilia and chromosome t(1;5) translocation","volume":"66","author":"Darbyshire","year":"1987","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0153_RF139","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood.V72.3.855.bloodjournal723855","article-title":"Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases","volume":"72","author":"Demory","year":"1988","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0153_RF140","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0165-4608(97)00255-0","article-title":"Translocation (1;20)(q32;q13\u00b73) in myelofibrosis following polycythemia vera","volume":"101","author":"Davidovitz","year":"1998","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF141","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0165-4608(84)90033-5","article-title":"Chromosome studies in polycythaemia vera patients","volume":"12","author":"Berger","year":"1984","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF142","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1046\/j.1365-2141.1999.01414.x","article-title":"A case of myelofibrosis with a t(4;13)(q25;q12): evidence for involvement of a second 13q12 locus in chronic myeloproliferative disorders","volume":"105","author":"MacDonald","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0153_RF143","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0165-4608(99)00043-6","article-title":"Translocation (X;5)(q13;q33) in essential thrombocythemia","volume":"114","author":"Munro","year":"1999","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1053\/beha.2001.0153_RF144","series-title":"Molecular Haematology","first-page":"85","article-title":"Myeloproliferative disorders","author":"Bench","year":"2000"},{"key":"10.1053\/beha.2001.0153_RF145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/geno.1997.4747","article-title":"Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia","volume":"42","author":"Kalachikov","year":"1997","journal-title":"Genomics"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T15:22:21Z","timestamp":1581002541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692601901537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":145,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S1521692601901537"],"URL":"https:\/\/doi.org\/10.1053\/beha.2001.0153","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}